Increased urinary catechol estrogen excretion in female smokers

Area of Science:

• Endocrinology
• Reproductive Health
• Environmental Health

Background:

• Cigarette smoking is linked to anti-estrogenic effects in premenopausal women.
• Estrogen metabolism, particularly hydroxylation pathways, plays a crucial role in reproductive health.

Purpose of the Study:

• To investigate whether increased estrogen 2-hydroxylation in premenopausal female smokers alters urinary estrogen excretion patterns.
• To compare the urinary profiles of five major estrogens between smokers and non-smokers.

Main Methods:

• Measurement of urinary estradiol (E2), estrone (E1), 16 alpha-hydroxyestrone (16 alpha OHE1), estriol (E3), and 2-hydroxyestrone (2OHE1).
• Analysis of urinary estrogen metabolites and calculation of a catechol estrogen index ([2OHE1]/[E3]).
• Correlation of urinary estrogen indices with radiometrically determined estrogen 2-hydroxylation.

Main Results:

• Urinary 2-hydroxyestrone (2OHE1) constituted a significantly greater proportion of total estrogens in smokers (31.1%) versus non-smokers (18.2%).
• Smokers showed significantly increased urinary 2OHE1 and decreased estriol (E3) levels.
• A significantly elevated urinary catechol estrogen index ([2OHE1]/[E3]) was observed in smokers, correlating strongly with estrogen 2-hydroxylation.

Conclusions:

• Premenopausal female smokers display a distinct estrogen metabolic profile characterized by enhanced 2-hydroxylation.
• Urinary estrogen indices can effectively differentiate between estrogen 2-hydroxylation and 16 alpha-hydroxylation metabolic pathways in specific populations.
• Altered estrogen metabolism in smokers may contribute to the observed anti-estrogenic effects of cigarette smoking.